MedTrace Logo

Invasive Left Heart Catheterization Registry

NCT04505449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 404

Last updated 2022-10-27

No results posted yet for this study

Summary

Retrospectively enrolled suspicious of heart failure with preserved ejection fraction (HFpEF) patients who underwent left heart catheterization with the measurement of left ventricular end-diastolic pressure.

Conditions

Interventions

DIAGNOSTIC_TEST

Left heart catheterization

Patients who underwent left heart catheterization

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jeong Hoon Yang, MD · Samsung Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-13
Primary Completion
2020-12-12
Completion
2021-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04505449 on ClinicalTrials.gov